Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2015; 25(04): 453-458
DOI: 10.4103/0971-3026.169447
Neuroradiology

Telltale signs of peripheral neurogenic tumors on magnetic resonance imaging

Chandan Kakkar
Department of Radiodiagnosis and Imaging, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
,
Chandrakant M Shetty
Department of Radiodiagnosis, Asian Heart Institute, Mumbai, Maharashtra, India
,
Prakashini Koteshwara
Department of Radiodiagnosis and Imaging, Kasturba Medical College and Hospital, Manipal, Karnataka, India
,
Surabhi Bajpai
Department of Abdominal Imaging, Massachusetts General Hospital, Boston, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Peripheral nerve sheath tumors are categorized into benign and malignant forms, comprising of neurofibroma and schwannoma in the benign category and malignant peripheral nerve sheath tumors in the malignant category. Magnetic resonance imaging plays an important role in the diagnosis of these lesions. The various imaging features and signs that help to identify and characterize a nerve sheath tumor are, distribution of the tumor along a major nerve, an entering or exiting nerve sign, target sign, a fascicular sign and a split-fat sign.

Keywords

Magnetic resonance imaging - neurofibroma - schwannoma - target sign


Publication History

Article published online:
30 July 2021

© 2015. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Kransdorf MJ, Murphey MD. Imaging of Soft Tissue Tumors. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006. p. 329-80.
  • 2 Kransdorf MJ. Benign soft-tissue tumors in a large referral population: Distribution of specific diagnoses by age, sex and location. AJR Am J Roentgenol 1995;164:395-402.
  • 3 Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: Distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995;164:129-34.
  • 4 Chee DW, Peh WC, Shek TW. Pictorial essay: Imaging of peripheral nerve sheath tumors. Can Assoc Radiol J 2011;62:176-82.
  • 5 Lin J, Martel W. Cross-sectional imaging of peripheral nerve sheath tumors: Characteristic signs on CT, MR Imaging and Sonography.AJR Am J Roentgenol 2001;176:75-82.
  • 6 Beaman FD, Kransdorf MJ, Menke DM. Schwannoma: Radiologic-pathologic correlation. Radiographics 2004;24:1477-81.
  • 7 Jee WH, Oh SN, McCauley T, Ryu KN, Suh JS, Lee JH, et al. Extraaxial neurofibromas versus neurilemmomas: Discrimination with MRI. AJR Am J Roentgenol 2004;183:629-33.
  • 8 Banks KP. The target sign: Extremity. Radiology 2005;234:899-900.
  • 9 Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: Radiologic-pathologic correlation. Radiographics 1999;19:1253-80.
  • 10 Stull MA, Moser RP Jr, Kransdorf MJ, Bogumill GP, Nelson MC. Magnetic resonance appearance of peripheral nerve sheath tumors. Skeletal Radiol 1991;20:9-14.
  • 11 Isobe K, Shimizu T, Akahane T, Kato H. Imaging of ancient schwannoma. AJR Am J Roentgenol 2004;183:331-6.
  • 12 Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, et al. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol 2010;194:1568-74.
  • 13 Benz MR, Czernin J, Dry SM, Tap WD, Allen-Auerbach MS, Elashoff D, et al. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer 2010;116:451-8.